Salvia BioElectronics secures $60M in oversubscribed Series B to bring its pioneering migraine therapy to market
/
DateMay 27 2025
Eindhoven, the Netherlands, May 27, 2025: Salvia BioElectronics, a clinical-stage medical device company pioneering neuromodulation therapy for people with chronic migraine, today announced the successful... Read More →